PARP1 and melanoma: In melanomas, PARP inhibitors promoted cell death in combination with temozolomide both in vitro and in clinical studies but the underlying mechanism of action remains to be elucidated (Plummer et al., 2013; Gill et al., 2015; Middleton et al., 2015).